CD274 and gastric cancer: In recent years, immune checkpoint inhibitors (ICIs), such as programmed cell death ligand-1 (PD-L1)/programmed death receptor-1 (PD-1) inhibitors, have significantly improved the survival outcomes for some advanced gastric cancer patients.